NICM
XRAY icon

Neo Ivy Capital Management’s Dentsply Sirona XRAY Stock Holding History

Neo Ivy Capital Management’s Portfolio XRAY Stock Details XRAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-180,542
Closed -$2.29M – 547
2025
Q3 		$2.29M Buy
+180,542
New +$2.62M 0.56% 57
2022
Q4 		– Sell
-4,196
Closed -$119K – 559
2022
Q3 		$119K Buy
4,196
+2,266
+117% +$77.5K 0.31% 128
2022
Q2 		$68K Sell
1,930
-164
-8% -$6.63K 0.18% 197
2022
Q1 		$104K Buy
+2,094
New +$111K 0.09% 297
2021
Q4 		– Sell
-616
Closed -$27K – 653
2021
Q3 		$27K Sell
616
-10,063
-94% -$620K 0.03% 374
2021
Q2 		$676K Buy
+10,679
New +$703K 0.68% 36
2021
Q1 		– Sell
-5,241
Closed -$274K – 640
2020
Q4 		$274K Buy
+5,241
New +$258K 0.31% 113
2020
Q3 		– Sell
-616
Closed -$27K – 641
2020
Q2 		$27K Buy
+616
New +$26K 0.03% 374
2020
Q1 		– Sell
-12,433
Closed -$704K – 560
2019
Q4 		$704K Buy
12,433
+131
+1% +$7.3K 0.81% 1
2019
Q3 		$642K Sell
12,302
-2,900
-19% -$156K 0.42% 97
2019
Q2 		$887K Buy
+15,202
New +$817K 0.5% 83

Other funds holding XRAY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return

Neo Ivy Capital Management's XRAY Position: Q4 2025 in Review

Neo Ivy Capital Management sold out of Dentsply Sirona (XRAY) in Q4 2025, closing a stake of 180,542 shares — an estimated $2.29M sold.

Neo Ivy Capital Management first reported a position in XRAY in Q2 2019 and held it in 11 quarters. The position peaked at $2.29M in Q3 2025. 360 funds tracked by Wall St. Rank hold XRAY as of Q4 2025.

  • Neo Ivy Capital Management reported no remaining Dentsply Sirona position as of Q4 2025 after selling out during the quarter.
  • Neo Ivy Capital Management sold 180,542 Dentsply Sirona shares in Q4 2025, an estimated $2.29M.
  • Neo Ivy Capital Management first reported a position in Dentsply Sirona in Q2 2019 and held it in 11 quarters.
  • Neo Ivy Capital Management's Dentsply Sirona position peaked at $2.29M in Q3 2025.
  • 360 funds tracked by Wall St. Rank held Dentsply Sirona as of Q4 2025.

Based on Neo Ivy Capital Management's 13F filing for Q4 2025, filed 13 Feb 2026.